Feb 12 (Reuters)- Immuno Biological Laboratories Co Ltd CONSOLIDATED FINANCIAL HIGHLIGHTS (in billions of yen unless specified) 9 months ended 9 months ended Year to Dec 31, 2025 Dec 31, 2024 Mar 31, 2026 LATEST YEAR-AGO LATEST RESULTS RESULTS FORECAST Sales 742 mln 680 mln 1.03 (+9.1 pct) (+24.0 pct) (+5.7 pct) Operating 223 mln 124 mln 240 mln (+79.1 pct) (+1058.9 pct) (+14.6 pct) Recurring 236 mln 129 mln 240 mln (+82.7 pct) (+401.0 pct) (+14.4 pct) Net 248 mln 133 mln 265 mln (+86.1 pct) (+547.7 pct) (+6.4 pct) EPS 26.65 yen 14.32 yen 28.45 yen Ann Div NIL 6.00 yen -Q2 div NIL NIL -Q4 div NIL 6.00 yen NOTE - Immuno Biological Laboratories Co Ltd. To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4570.T